Clinical trial
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With…
NCT00021320 · Fox Chase Cancer Center, Other · Completed
Key facts
| NCT number | NCT00021320 |
|---|---|
| Title | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer |
| Official title | Phase II Evaluation Of Paclitaxel, Cisplatin And 5-Fluorouracil Given In Combination With Radiation Therapy Prior To Surgery In Patients With Resectable Esophageal Cancer |
| Lead sponsor | Fox Chase Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | cisplatin, fluorouracil, paclitaxel, conventional surgery, neoadjuvant therapy, radiation therapy |
| Enrollment | 21 |
| Start date | May 1, 2000 |
| Primary completion | Jan 1, 2004 |
| Completion | Apr 1, 2009 |
| First posted | Jan 27, 2003 |
| Last update posted | May 9, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: